In in vitro studies, two BRD4 inhibitors (JQ1 and I-BET762) have been found to effectively inhibit the proliferation and growth of cancer cells such as melanoma, pancreatic cancer, lung cancer, multiple myeloma, acute myeloid leukemia, and Burkitt's lymphoma [14, 19, 21–23]. Here, BRD4 is linked to cancer.